INMB (INmune Bio) Inventories, Other: $0.00 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

INMB INmune Bio Inc INMB
57 GF Score
Price $2.09
GF Value $1.79
Valuation Modestly Overvalued
! 5 Warning Signs
View Full Analysis

What is INmune Bio Inventories, Other?

INmune Bio INMB +9.45% 57 Inventories, Other is $0.00 Mil as of Jun. 2026. GuruFocus rates INMB with a GF Score™ of 57/100 and a GF Value™ of $1.79 (Modestly Overvalued). The stock has 5 warning signs investors should review.

Other inventories including goods for resale, stocks in transit, consignment stocks, etc. INmune Bio's other inventories for the quarter that ended in Jun. 2026 was $0.00 Mil.

INmune Bio Inventories, Other Historical Data

* Premium members only.

The historical data trend for INmune Bio's Inventories, Other can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

INmune Bio Inventories, Other Chart

INmune Bio Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Inventories, Other
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

INmune Bio Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Inventories, Other Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
INMB
57GF Score
INmune Bio Inc INMB
Inventories, Other is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

INmune Bio Inventories, Other Calculation

Other inventories including goods for resale, stocks in transit, consignment stocks, etc.

Frequently Asked Questions Learn more about Inventories, Other →
What does a Inventories, Other of $0.00 Mil mean?
INmune Bio (INMB) has a Inventories, Other of $0.00 Mil as of Jun. 2026. Other inventories a company records on its balance sheet, like goods for resale and stocks in transit. View historical data on INmune Bio and its competitors.
Is INmune Bio's Inventories, Other too high?
INmune Bio's current Inventories, Other is $0.00 Mil. Overall, INmune Bio has a GF Score™ of 57/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does INmune Bio's Inventories, Other compare to FLNA and DYAI?
INmune Bio's Inventories, Other of $0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventories, Other for a Biotechnology company?
A good Inventories, Other depends on the Biotechnology industry context. However, Inventories, Other should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventories, Other mean?
A high Inventories, Other can signal that a stock is expensive relative to its fundamentals. Other inventories a company records on its balance sheet, like goods for resale and stocks in transit. View historical data on INmune Bio and its competitors. INmune Bio's current Inventories, Other is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is INmune Bio stock overvalued right now?
Based on GuruFocus' analysis, INmune Bio (INMB) is currently considered Modestly Overvalued. The stock's GF Value™ is $1.79, compared to a current price of $2.09 — trading 16.8% above its estimated fair value. The current Inventories, Other is $0.00 Mil. INmune Bio's overall GF Score™ is 57/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventories, Other calculated?
Inventories, Other is calculated from a company's financial statements. For INmune Bio (INMB), the current Inventories, Other is $0.00 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is INmune Bio (INMB) Overvalued in 2026?

Based on GuruFocus' analysis, INmune Bio stock appears to be overvalued. The current stock price of $2.09 is trading 16.8% above its estimated GF Value™ of $1.79. GuruFocus considers INmune Bio to be Modestly Overvalued.

Key valuation signals for INMB:

  • Inventories, Other: $0.00 Mil
  • GF Value™: $1.79 vs. price of $2.09 (16.8% above fair value)
  • GF Score™: 57/100 with 5 warning signs

No single metric tells the full story. See the INMB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

INmune Bio Business Description

Address 225 NE Mizner Boulevard, Suite 640, Boca Raton, FL, USA, 33432
INmune Bio Inc is a clinical stage biotechnology pharmaceutical company focused on developing and commercializing its product candidates to treat diseases where inflammation and immunology cause a dysfunctional immune system contributing to disease. The company's pipeline products include INKmune, XPro1595, and others. It has three product platforms; The CORDStrom product platform, The DN-TNF product platform, and The Natural Killer Cell Priming Platform.
57GF Score

Get the complete analysis for INMB

Inventories, Other is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.09
Price
$1.79
GF Value